Clinical Trials Directory

Trials / Completed

CompletedNCT06779994

The Safety and Efficacy of Probiotic for Improving Intestinal and Immune Function

Safety and Efficacy of Streptococcus Salivarius Subsp. Thermophilus ST36 on Intestinal and Immune Function Improvement.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
98 (actual)
Sponsor
Wecare Probiotics Co., Ltd. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

To evaluate the safety and efficacy of Streptococcus salivarius subsp. thermophilus ST36 in healthy adults on immune function and intestinal health.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticThe experimental phase of this study will last 8 weeks and each subject will have three visits (day 0, week 4 and week 8).
DIETARY_SUPPLEMENTPlaceboThe experimental phase of this study will last 8 weeks and each subject will have three visits (day 0, week 4 and week 8).

Timeline

Start date
2025-04-10
Primary completion
2025-05-06
Completion
2025-08-20
First posted
2025-01-17
Last updated
2025-08-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06779994. Inclusion in this directory is not an endorsement.

The Safety and Efficacy of Probiotic for Improving Intestinal and Immune Function (NCT06779994) · Clinical Trials Directory